These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 413914)

  • 21. Trypanosoma cruzi: monoclonal antibody to cytoskeleton recognizes giant proteins of the flagellar attachment zone.
    Ruiz-Moreno L; Bijovsky AT; Pudles J; Alves MJ; Colli W
    Exp Parasitol; 1995 Jun; 80(4):605-15. PubMed ID: 7758541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chagas' disease: humoral response to subcellular fraction of Trypanosoma cruzi in symptomatic and asymptomatic patients.
    de Titto EH; Moreno M; Braun M; Segura EL
    Trop Med Parasitol; 1987 Sep; 38(3):163-6. PubMed ID: 3124252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi: shedding of surface antigens as membrane vesicles.
    Gonçalves MF; Umezawa ES; Katzin AM; de Souza W; Alves MJ; Zingales B; Colli W
    Exp Parasitol; 1991 Jan; 72(1):43-53. PubMed ID: 1993464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Flagellar antigens and the leucocyte migration-inhibition test in Chagas patients.
    Patrucco A; Cerisola JA; Michel M; Chiale P; Alvarez M; Segura EL
    Trans R Soc Trop Med Hyg; 1978; 72(4):425-6. PubMed ID: 100910
    [No Abstract]   [Full Text] [Related]  

  • 25. Cellular response to Trypanosoma cruzi infection induces secretion of defensin α-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.
    Johnson CA; Rachakonda G; Kleshchenko YY; Nde PN; Madison MN; Pratap S; Cardenas TC; Taylor C; Lima MF; Villalta F
    Infect Immun; 2013 Nov; 81(11):4139-48. PubMed ID: 23980110
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunization against Trypanosoma cruzi using killed antigens and with saponin as adjuvant.
    Neal RA; Johnson P
    Acta Trop; 1977 Mar; 34(1):87-96. PubMed ID: 16471
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trypanosoma cruzi: identification of a surface antigen restricted to the flagellar region of the infective form of the parasite.
    Saborio JL; Wrightsman RA; Kazuko SG; Granger BS; Manning JE
    Exp Parasitol; 1990 May; 70(4):411-8. PubMed ID: 2182336
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of Trypanosoma cruzi in different animal species.
    Rubiolo ER
    Acta Physiol Lat Am; 1981; 31(3):199-206. PubMed ID: 6821271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of cell mediated immunity to flagellar antigens and acquired resistance to infection by Trypanosoma cruzi in mice.
    Gonçalves da Costa SC; Lagrande PH
    Mem Inst Oswaldo Cruz; 1981; 76(4):367-81. PubMed ID: 6217394
    [No Abstract]   [Full Text] [Related]  

  • 30. Trypanosoma cruzi: immune response in mice immunized with parasite antigens.
    Rottenberg ME; Cardoni RL; deTitto EH; Moreno M; Segura EL
    Exp Parasitol; 1988 Feb; 65(1):101-8. PubMed ID: 2892694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro synthesis of Trypanosoma cruzi antigenic polypeptides.
    Stolf AM; Santos CL; Brentani R; Camargo ME
    Infect Immun; 1983 Mar; 39(3):1175-9. PubMed ID: 6404819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody response and antigen recognition in human infection with Trypanosoma cruzi.
    Israelski DM; Sadler R; Araujo FG
    Am J Trop Med Hyg; 1988 Nov; 39(5):445-55. PubMed ID: 3143270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Freeze-fracture localization of filipin-cholesterol complexes in the plasma membrane of Trypanosoma cruzi.
    Souto-Padrón T; de Souza W
    J Parasitol; 1983 Feb; 69(1):129-37. PubMed ID: 6402578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.
    Madison MN; Kleshchenko YY; Nde PN; Simmons KJ; Lima MF; Villalta F
    Infect Immun; 2007 Oct; 75(10):4780-91. PubMed ID: 17635867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of the flagellar surface of protists by atomic force microscopy.
    Rocha GM; Miranda K; Weissmüller G; Bisch PM; de Souza W
    Micron; 2010 Dec; 41(8):939-44. PubMed ID: 20719525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunoprotective effect of the flagellar fraction obtained from different Trypanosoma cruzi homogenates].
    Esteva M; Moras EV; Subías E; Segura EL
    Medicina (B Aires); 1980; 40 Suppl 1():257. PubMed ID: 7005612
    [No Abstract]   [Full Text] [Related]  

  • 37. [Molecular and immunologic bases for the development of a vaccine against Chagas disease].
    Segura EL; Cardoni RL; Búa J; Rottenberg ME; Bontempi EJ; Esteva MI; Carlomagno MA; De Titto EH; Ruiz AM
    Medicina (B Aires); 1989; 49(3):203-9. PubMed ID: 2518642
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenicity of fractions of a somatic antigen of Trypanosoma cruzi.
    González Cappa SM; Kagan IG
    J Parasitol; 1973 Dec; 59(6):1080-4. PubMed ID: 4202516
    [No Abstract]   [Full Text] [Related]  

  • 39. Antigenic differences among epimastigotes, amastigotes and trypomastigotes of Trypanosoma cruzi.
    Kloetzel J; Camargo ME; Giovannini VL
    J Protozool; 1975 May; 22(2):259-61. PubMed ID: 807718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms.
    Sangenito LS; Menna-Barreto RFS; Oliveira AC; d'Avila-Levy CM; Branquinha MH; Santos ALS
    Int J Antimicrob Agents; 2018 Aug; 52(2):185-194. PubMed ID: 29635008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.